{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:55:48Z","timestamp":1791971748270,"version":"4.3.4"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.aicoj.2025.100014","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:26:35Z","timestamp":1768843595000},"page":"100014","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Emerging role of nucleic acid aptamers in sepsis-induced coagulopathy: Future perspectives in diagnostics and therapeutics"],"prefix":"10.1016","volume":"16","author":[{"given":"Maeva","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Tschirhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Auger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Toti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Helms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Choulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.aicoj.2025.100014_bib0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"issue":"10219","key":"10.1016\/j.aicoj.2025.100014_bib0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"The Lancet."},{"issue":"5663","key":"10.1016\/j.aicoj.2025.100014_bib0015","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13613-017-0339-5","article-title":"Immunohaemostasis: a new view on haemostasis during sepsis","volume":"7","author":"Delabranche","year":"2017","journal-title":"Ann Intensive Care."},{"issue":"6","key":"10.1016\/j.aicoj.2025.100014_bib0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/SHK.0000000000000680","article-title":"Extracellular Histones Increase Tissue Factor Activity and Enhance Thrombin Generation by Human Blood Monocytes","volume":"46","author":"Gould","year":"2016","journal-title":"Shock Augusta Ga."},{"key":"10.1016\/j.aicoj.2025.100014_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtha.2025.03.038","article-title":"Updated definition and scoring of Disseminated Intravascular Coagulation in 2025: communication from the ISTH SSC Subcommittee on Disseminated Intravascular Coagulation","author":"Iba","year":"2025","journal-title":"J Thromb Haemost."},{"issue":"17","key":"10.1016\/j.aicoj.2025.100014_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells12172120","article-title":"Pathophysiology of Disseminated Intravascular Coagulation in Sepsis: A Clinically Focused Overview","volume":"12","author":"Unar","year":"2023","journal-title":"Cells."},{"issue":"13","key":"10.1016\/j.aicoj.2025.100014_bib0040","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1182\/blood.2020007208","article-title":"Disseminated intravascular coagulation and its immune mechanisms","volume":"139","author":"Popescu","year":"2022","journal-title":"Blood."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100014_bib0045","first-page":"14270","article-title":"DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma","volume":"33","author":"Cruz","year":"2019","journal-title":"FASEB J Off Publ Fed Am Soc Exp Biol."},{"issue":"3","key":"10.1016\/j.aicoj.2025.100014_bib0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrd.2016.199","article-title":"Aptamers as targeted therapeutics: current potential and challenges","volume":"16","author":"Zhou","year":"2017","journal-title":"Nat Rev Drug Discov."},{"issue":"8","key":"10.1016\/j.aicoj.2025.100014_bib0055","doi-asserted-by":"crossref","first-page":"9500","DOI":"10.1021\/acsami.0c05750","article-title":"Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications","volume":"13","author":"Ni","year":"2021","journal-title":"ACS Appl Mater Interfaces."},{"issue":"4968","key":"10.1016\/j.aicoj.2025.100014_bib0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA Polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science."},{"issue":"6287","key":"10.1016\/j.aicoj.2025.100014_bib0065","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.aicoj.2025.100014_bib0070","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.omtn.2023.07.038","article-title":"A neutralizable dimeric anti-thrombin aptamer with potent anticoagulant activity in mice","volume":"33","author":"Nagano","year":"2023","journal-title":"Mol Ther - Nucleic Acids."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10404-022-02622-3","article-title":"Aptamer-based rapid diagnosis for point-of-care application","volume":"27","author":"Futane","year":"2023","journal-title":"Microfluid Nanofluidics."},{"issue":"11","key":"10.1016\/j.aicoj.2025.100014_bib0080","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24725","article-title":"Aptamers: A prospective tool for infectious diseases diagnosis","volume":"36","author":"Chen","year":"2022","journal-title":"J Clin Lab Anal."},{"key":"10.1016\/j.aicoj.2025.100014_bib0085","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bios.2017.11.028","article-title":"Nucleic acid aptamer-based methods for diagnosis of infections","volume":"102","author":"Park","year":"2018","journal-title":"Biosens Bioelectron."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12929-019-0611-0","article-title":"Therapeutic applications of nucleic acid aptamers in microbial infections","volume":"27","author":"Afrasiabi","year":"2020","journal-title":"J Biomed Sci."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0095","first-page":"150","article-title":"Endothelial dysfunction in sepsis","volume":"11","author":"Boisram\u00e9-Helms","year":"2013","journal-title":"Curr Vasc Pharmacol."},{"issue":"10","key":"10.1016\/j.aicoj.2025.100014_bib0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096846","article-title":"Anti-Heparanase Aptamers as Potential Diagnostic and Therapeutic Agents for Oral Cancer","volume":"9","author":"Simmons","year":"2014","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100014_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/nat.2019.0833","article-title":"Anti-CD44 DNA Aptamers Selectively Target Cancer Cells","volume":"30","author":"P\u0119cak","year":"2020","journal-title":"Nucleic Acid Ther."},{"issue":"17","key":"10.1016\/j.aicoj.2025.100014_bib0110","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm8965","article-title":"Lactate induces vascular permeability via disruption of VE-cadherin in endothelial cells during sepsis","volume":"8","author":"Yang","year":"2022","journal-title":"Sci Adv."},{"issue":"13","key":"10.1016\/j.aicoj.2025.100014_bib0115","article-title":"Endothelial cell dysfunction and targeted therapeutic drugs in sepsis","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon."},{"key":"10.1016\/j.aicoj.2025.100014_bib0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.cyto.2016.08.028","article-title":"Endothelial adhesion molecules and multiple organ failure in patients with severe sepsis","volume":"88","author":"Amalakuhan","year":"2016","journal-title":"Cytokine."},{"issue":"3","key":"10.1016\/j.aicoj.2025.100014_bib0125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1164\/ajrccm.157.3.9705034","article-title":"Elevated Circulating E-Selectin, Intercellular Adhesion Molecule 1, and von Willebrand Factor in Patients with Severe Infection","volume":"157","author":"Kayal","year":"1998","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.aicoj.2025.100014_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114262","article-title":"Inhibition of Cell Migration and Invasion by ICAM-1 Binding DNA Aptamers","volume":"628","author":"\u015eener","year":"2021","journal-title":"Anal Biochem."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0135","article-title":"A novel specific aptamer targets cerebrovascular endothelial cells after ischemic stroke","volume":"13","author":"Hu","year":"2023","journal-title":"Sci Rep."},{"issue":"7","key":"10.1016\/j.aicoj.2025.100014_bib0140","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1073\/pnas.96.7.3606","article-title":"Cytoplasmic RNA modulators of an inside-out signal-transduction cascade","volume":"96","author":"Blind","year":"1999","journal-title":"Proc Natl Acad Sci USA."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1182\/blood-2010-05-285718","article-title":"Inhibition of cell adhesion by anti\u2013P-selectin aptamer: a new potential therapeutic agent for sickle cell disease","volume":"117","author":"Gutsaeva","year":"2011","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093173","article-title":"SDA, a DNA Aptamer Inhibiting E- and P-Selectin Mediated Adhesion of Cancer and Leukemia Cells, the First and Pivotal Step in Transendothelial Migration during Metastasis Formation","volume":"9","author":"Faryammanesh","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.aicoj.2025.100014_bib0155","first-page":"14","article-title":"Endothelial dysfunction and immunothrombosis in sepsis","author":"Maneta","year":"2023","journal-title":"Front Immunol [Internet]"},{"issue":"15","key":"10.1016\/j.aicoj.2025.100014_bib0160","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.bmcl.2004.05.042","article-title":"Aptamer selection for the inhibition of cell adhesion with fibronectin as target","volume":"14","author":"Ogawa","year":"2004","journal-title":"Bioorg Med Chem Lett."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247017","article-title":"Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients","volume":"16","author":"Singh","year":"2021","journal-title":"PLoS One."},{"issue":"23","key":"10.1016\/j.aicoj.2025.100014_bib0170","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1161\/CIRCULATIONAHA.107.724864","article-title":"First-in-Human Evaluation of Anti\u2013von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers","volume":"116","author":"Gilbert","year":"2007","journal-title":"Circulation."},{"issue":"21","key":"10.1016\/j.aicoj.2025.100014_bib0175","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V118.21.3377.3377","article-title":"Inhibition of Von Willebrand Factor (VWF) by ARC1779 Normalizes Von Willebrand Factor\/FVIII Levels and Corrects Thrombocytopenia in VWD Type 2b Patients","volume":"118","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Blood."},{"issue":"9","key":"10.1016\/j.aicoj.2025.100014_bib0180","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1160\/TH11-02-0069","article-title":"A dose ranging phase I\/II trial of the von Willebrand factor inhibiting aptamer ARC1779 in patients with congenital thrombotic thrombo - cytopenic purpura","volume":"106","author":"Jilma-Stohlawetz","year":"2011","journal-title":"Thromb Haemost."},{"issue":"3","key":"10.1016\/j.aicoj.2025.100014_bib0185","first-page":"563","article-title":"A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease","volume":"104","author":"Jilma","year":"2010","journal-title":"Thromb Haemost."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100014_bib0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/09537100903085927","article-title":"The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction","volume":"20","author":"Spiel","year":"2009","journal-title":"Platelets."},{"issue":"8","key":"10.1016\/j.aicoj.2025.100014_bib0195","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/STROKEAHA.111.616649","article-title":"The von Willebrand Inhibitor ARC1779 Reduces Cerebral Embolization After Carotid Endarterectomy","volume":"42","author":"Markus","year":"2011","journal-title":"Stroke."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68125-9","article-title":"The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin","volume":"10","author":"Kovacevic","year":"2020","journal-title":"Sci Rep."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0205","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/ATVBAHA.111.237529","article-title":"ARC15105 Is a Potent Antagonist of Von Willebrand Factor Mediated Platelet Activation and Adhesion","volume":"32","author":"Siller-Matula","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"11","key":"10.1016\/j.aicoj.2025.100014_bib0210","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.3324\/haematol.2019.235549","article-title":"Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab","volume":"105","author":"Sakai","year":"2019","journal-title":"Haematologica."},{"issue":"3","key":"10.1016\/j.aicoj.2025.100014_bib0215","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/oli.2007.0089","article-title":"Antidote-Controlled Platelet Inhibition Targeting von Willebrand Factor with Aptamers","volume":"17","author":"Oney","year":"2007","journal-title":"Oligonucleotides."},{"issue":"7","key":"10.1016\/j.aicoj.2025.100014_bib0220","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ymthe.2019.03.016","article-title":"Preclinical Development of a vWF Aptamer to Limit Thrombosis and Engender Arterial Recanalization of Occluded Vessels","volume":"27","author":"Nimjee","year":"2019","journal-title":"Mol Ther."},{"issue":"suppl_21","key":"10.1016\/j.aicoj.2025.100014_bib0225","article-title":"Abstract 10787: Discovery of a Novel Aptamer-based Inhibitor of GPVI and its Matched Active Control Agent","volume":"122","author":"Rusconi","year":"2010","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.aicoj.2025.100014_bib0230","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/iub.461","article-title":"Structural basis of thrombin\u2013protease-activated receptor interactions","volume":"63","author":"Gandhi","year":"2011","journal-title":"IUBMB Life."},{"issue":"19","key":"10.1016\/j.aicoj.2025.100014_bib0235","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A role for factor XIIa\u2013mediated factor XI activation in thrombus formation in vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.aicoj.2025.100014_bib0240","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12302","article-title":"Inhibiting the intrinsic pathway of coagulation with a FXII-targeting RNA Aptamer","volume":"11","author":"Woodruff","year":"2013","journal-title":"J Thromb Haemost JTH."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-02055-x","article-title":"Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa","volume":"7","author":"Donkor","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.aicoj.2025.100014_bib0250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.thromres.2017.06.015","article-title":"Generation and characterization of aptamers targeting factor XIa","volume":"156","author":"Woodruff","year":"2017","journal-title":"Thromb Res."},{"issue":"3","key":"10.1016\/j.aicoj.2025.100014_bib0255","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2217\/fca.12.5","article-title":"The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome","volume":"8","author":"Vavalle","year":"2012","journal-title":"Future Cardiol"},{"issue":"10016","key":"10.1016\/j.aicoj.2025.100014_bib0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0140-6736(15)00515-2","article-title":"Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial","volume":"387","author":"Lincoff","year":"2016","journal-title":"Lancet Lond Engl."},{"issue":"suppl_16","key":"10.1016\/j.aicoj.2025.100014_bib0265","article-title":"Abstract 1555: Antidote-Controlled Modulation of Factor IXa Activity with the First-in-Class REG1 Anticoagulation System: A Randomized Phase 1 Repeat Dose Safety and Antidote Dose-Escalation Study","volume":"116","author":"Chan","year":"2007","journal-title":"Circulation."},{"key":"10.1016\/j.aicoj.2025.100014_bib0270","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.omtn.2021.12.011","article-title":"Aptamer-based factor IXa inhibition preserves hemostasis and prevents thrombosis in a piglet model of ECMO","volume":"27","author":"Reed","year":"2022","journal-title":"Mol Ther - Nucleic Acids."},{"issue":"11","key":"10.1016\/j.aicoj.2025.100014_bib0275","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1055\/s-0037-1614126","article-title":"Blocking the Initiation of Coagulation by RNA Aptamers to Factor VIIa","volume":"84","author":"Rusconi","year":"2000","journal-title":"Thromb Haemost."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0280","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.chembiol.2022.01.009","article-title":"Generation of an anticoagulant aptamer that targets factor V\/Va and disrupts the FVa-membrane interaction in normal and COVID-19 patient samples","volume":"29","author":"Soule","year":"2022","journal-title":"Cell Chem Biol"},{"issue":"7","key":"10.1016\/j.aicoj.2025.100014_bib0285","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nbt.4153","article-title":"Combination of aptamer and drug for reversible anticoagulation in cardiopulmonary bypass","volume":"36","author":"Gunaratne","year":"2018","journal-title":"Nat Biotechnol."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/nat.2015.0565","article-title":"Targeting Two Coagulation Cascade Proteases with a Bivalent Aptamer Yields a Potent and Antidote-Controllable Anticoagulant","volume":"26","author":"Soule","year":"2016","journal-title":"Nucleic Acid Ther."},{"issue":"19","key":"10.1016\/j.aicoj.2025.100014_bib0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910803","article-title":"Exosite Binding in Thrombin: A Global Structural\/Dynamic Overview of Complexes with Aptamers and Other Ligands","volume":"22","author":"Troisi","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"6360","key":"10.1016\/j.aicoj.2025.100014_bib0300","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/355564a0","article-title":"Selection of single-stranded DNA molecules that bind and inhibit human thrombin","volume":"355","author":"Bock","year":"1992","journal-title":"Nature."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100014_bib0305","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood.V81.12.3271.3271","article-title":"In Vivo Anticoagulant Properties of a Novel Nucleotide-Based Thrombin Inhibitor and Demonstration of Regional Anticoagulation in Extracorporeal Circuits","volume":"81","author":"Griffin","year":"1993","journal-title":"Blood."},{"issue":"23","key":"10.1016\/j.aicoj.2025.100014_bib0310","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00018-006-6219-z","article-title":"Direct thrombin inhibitors \u2013 a survey of recent developments","volume":"63","author":"Schwienhorst","year":"2006","journal-title":"Cell Mol Life Sci CMLS."},{"key":"10.1016\/j.aicoj.2025.100014_bib0315","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.omtn.2019.03.002","article-title":"Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX","volume":"16","author":"Wakui","year":"2019","journal-title":"Mol Ther - Nucleic Acids."},{"key":"10.1016\/j.aicoj.2025.100014_bib0320","first-page":"10","article-title":"Comparison of Effects of Anti-Thrombin Aptamers HD1 and HD22 on Aggregation of Human Platelets, Thrombin Generation, Fibrin Formation, and Thrombus Formation Under Flow Conditions","author":"Derszniak","year":"2019","journal-title":"Front Pharmacol [Internet]"},{"issue":"6","key":"10.1016\/j.aicoj.2025.100014_bib0325","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1006\/mthe.2001.0495","article-title":"Generation of Species Cross-reactive Aptamers Using \u201cToggle\u201d SELEX","volume":"4","author":"White","year":"2001","journal-title":"Mol Ther."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100014_bib0330","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/j.1538-7836.2008.03162.x","article-title":"Anticoagulant characteristics of HD1\u201022, a bivalent aptamer that specifically inhibits thrombin and prothrombinase","volume":"6","author":"M\u00fcller","year":"2008","journal-title":"J Thromb Haemost."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100014_bib0335","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12503","article-title":"Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high\u2010anticoagulant thrombin\u2010binding bivalent DNA aptamer\u2010linked M08 with HD22","volume":"5","author":"Yoshitomi","year":"2021","journal-title":"Res Pract Thromb Haemost."},{"issue":"3","key":"10.1016\/j.aicoj.2025.100014_bib0340","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00134-023-06980-6","article-title":"How to manage coagulopathies in critically ill patients","volume":"49","author":"Helms","year":"2023","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0345","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ccc.2019.12.002","article-title":"Role of Antithrombin III and Tissue Factor Pathway in the Pathogenesis of Sepsis","volume":"36","author":"Sungurlu","year":"2020","journal-title":"Crit Care Clin."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0350","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/nat.2022.0047","article-title":"Positive Allosteric Modulation of Antithrombin\u2019s Inhibitory Activity by RNA Aptamers","volume":"33","author":"Zaman","year":"2023","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.aicoj.2025.100014_bib0355","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-23056-1_3","article-title":"The anticoagulant and antithrombotic mechanisms of heparin","author":"Gray","year":"2012","journal-title":"Handb Exp Pharmacol [Internet]"},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0360","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40560-015-0075-6","article-title":"Recent advances in disseminated intravascular coagulation: endothelial cells and fibrinolysis in sepsis-induced DIC","volume":"3","author":"Madoiwa","year":"2015","journal-title":"J Intensive Care."},{"key":"10.1016\/j.aicoj.2025.100014_bib0365","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13613-019-0499-6","article-title":"Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study","volume":"9","author":"Schmitt","year":"2019","journal-title":"Ann Intensive Care."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0370","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/nat.2013.0475","article-title":"Inhibition of PAI-1 Antiproteolytic Activity Against tPA by RNA Aptamers","volume":"24","author":"Damare","year":"2014","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.aicoj.2025.100014_bib0375","series-title":"In: StatPearls [Internet]","article-title":"Physiology, Factor XIII","author":"Malkhassian","year":"2024"},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0380","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/jcm10040677","article-title":"Functional and Structural Characterization of Nucleic Acid Ligands That Bind to Activated Coagulation Factor XIII","volume":"10","author":"Hamedani","year":"2021","journal-title":"J Clin Med."},{"issue":"11","key":"10.1016\/j.aicoj.2025.100014_bib0385","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1161\/01.ATV.0000244680.14653.9a","article-title":"Regulation of Fibrinolysis by Thrombin Activatable Fibrinolysis Inhibitor, an Unstable Carboxypeptidase B That Unites the Pathways of Coagulation and Fibrinolysis","volume":"26","author":"Mosnier","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0390","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4049\/jimmunol.1100588","article-title":"Neutrophil Mobilization from the Bone Marrow during Polymicrobial Sepsis Is Dependent on CXCL12 Signaling","volume":"187","author":"Delano","year":"2011","journal-title":"J Immunol."},{"issue":"9","key":"10.1016\/j.aicoj.2025.100014_bib0395","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.20141813","article-title":"Phospholipase D2 drives mortality in sepsis by inhibiting neutrophil extracellular trap formation and down-regulating CXCR2","volume":"212","author":"Lee","year":"2015","journal-title":"J Exp Med."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0400","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41467-018-08030-y","article-title":"RNA inhibitors of nuclear proteins responsible for multiple organ dysfunction syndrome","volume":"10","author":"Urak","year":"2019","journal-title":"Nat Commun."},{"issue":"11","key":"10.1016\/j.aicoj.2025.100014_bib0405","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0960-9822(06)00376-9","article-title":"Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury","volume":"7","author":"Bless","year":"1997","journal-title":"Curr Biol."},{"issue":"6","key":"10.1016\/j.aicoj.2025.100014_bib0410","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/ijms9061008","article-title":"Effective DNA Inhibitors of Cathepsin G by In Vitro Selection","volume":"9","author":"Gatto","year":"2008","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.aicoj.2025.100014_bib0415","series-title":"Current Topics in Complement II [Internet]","first-page":"68","article-title":"Interaction Between the Coagulation and Complement System","author":"Amara","year":"2008"},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0420","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","article-title":"Thrombomodulin and its role in inflammation","volume":"34","author":"Conway","year":"2012","journal-title":"Semin Immunopathol."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0425","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/CDLI.10.4.529-535.2003","article-title":"Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis","volume":"10","author":"Zeerleder","year":"2003","journal-title":"Clin Vaccine Immunol."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0430","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4049\/jimmunol.2001260","article-title":"Inhibition of the Complement Alternative Pathway by Chemically Modified DNA Aptamers That Bind with Picomolar Affinity to Factor B","volume":"206","author":"Xu","year":"2021","journal-title":"J Immunol Author Choice."},{"key":"10.1016\/j.aicoj.2025.100014_bib0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Transl Res."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0440","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1128\/cdli.3.2.175-183.1996","article-title":"Circulating Complement Proteins in Patients with Sepsis or Systemic Inflammatory Response Syndrome","volume":"3","author":"St\u00f6ve","year":"1996","journal-title":"Clin Diagn Lab Immunol."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0445","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/0002-9343(89)90224-6","article-title":"Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis","volume":"86","author":"Hack","year":"1989","journal-title":"Am J Med."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0450","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb Haemost."},{"issue":"7","key":"10.1016\/j.aicoj.2025.100014_bib0455","first-page":"4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J Immunol Baltim Md 1950"},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0460","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V100.2.517","article-title":"C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils","volume":"100","author":"Wojta","year":"2002","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100014_bib0465","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1097\/MS9.0000000000002021","article-title":"\u201cIzervay (avacincaptad pegol): paving the way for vision preservation in geographic atrophy\u201d","volume":"86","author":"Shakeel","year":"2024","journal-title":"Ann Med Surg."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100014_bib0470","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/mt.2013.178","article-title":"A Novel C5a-neutralizing Mirror-image (l-)Aptamer Prevents Organ Failure and Improves Survival in Experimental Sepsis","volume":"21","author":"Hoehlig","year":"2013","journal-title":"Mol Ther."},{"issue":"11","key":"10.1016\/j.aicoj.2025.100014_bib0475","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V110.11.3976.3976","article-title":"Relationship between Procalcitonin Levels and Severity of DIC Induced by Bacterial Infection","volume":"110","author":"Kawasugi","year":"2007","journal-title":"Blood."},{"issue":"22","key":"10.1016\/j.aicoj.2025.100014_bib0480","first-page":"11953","article-title":"Procalcitonin is a predictor of disseminated intravascular coagulation in patients with fatal COVID-19","volume":"24","author":"Aso\u011flu","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1016\/j.aicoj.2025.100014_bib0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2022.133107","article-title":"OFF-ON on-the-fly aptassay for rapid and accurate determination of procalcitonin in very low birth weight infants with sepsis suspicion","volume":"378","author":"Gord\u00f3n Pidal","year":"2023","journal-title":"Sens Actuators B Chem."},{"key":"10.1016\/j.aicoj.2025.100014_bib0490","doi-asserted-by":"crossref","first-page":"17","DOI":"10.15586\/aei.v52i3.1039","article-title":"The prognostic value of platelet aggregation in patients with sepsis","volume":"52","author":"Chen","year":"2024","journal-title":"Allergol Immunopathol (Madr)."},{"issue":"23","key":"10.1016\/j.aicoj.2025.100014_bib0495","article-title":"Development of a CD63 Aptamer for Efficient Cancer Immunochemistry and Immunoaffinity-Based Exosome Isolation","volume":"25","author":"Song","year":"2020","journal-title":"Mol Basel Switz."},{"issue":"7","key":"10.1016\/j.aicoj.2025.100014_bib0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131785","article-title":"Isolation of Foreign Material-Free Endothelial Progenitor Cells Using CD31 Aptamer and Therapeutic Application for Ischemic Injury","volume":"10","author":"Yoon","year":"2015","journal-title":"PloS One."},{"issue":"17","key":"10.1016\/j.aicoj.2025.100014_bib0505","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1039\/D1CC03817F","article-title":"Fibrinogen aptamer functionalized gold-coated iron-oxide nanoparticles for targeted imaging of thrombi","volume":"58","author":"Koudrina","year":"2022","journal-title":"Chem Commun."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100014_bib0510","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb Haemost."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0515","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13054-021-03545-1","article-title":"Endothelial damage in septic shock patients as evidenced by circulating syndecan-1, sphingosine-1-phosphate and soluble VE-cadherin: a substudy of ALBIOS","volume":"25","author":"Piotti","year":"2021","journal-title":"Crit Care."},{"issue":"Pt 1","key":"10.1016\/j.aicoj.2025.100014_bib0520","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1042\/BJ20131422","article-title":"Identification and characterization of a mirror-image oligonucleotide that binds and neutralizes sphingosine 1-phosphate, a central mediator of angiogenesis","volume":"462","author":"Purschke","year":"2014","journal-title":"Biochem J."},{"issue":"6","key":"10.1016\/j.aicoj.2025.100014_bib0525","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/cvx023","article-title":"Endothelial glycocalyx breakdown is mediated by angiopoietin-2","volume":"113","author":"Lukasz","year":"2017","journal-title":"Cardiovasc Res."},{"issue":"9","key":"10.1016\/j.aicoj.2025.100014_bib0530","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.1073\/pnas.0831159100","article-title":"Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2","volume":"100","author":"White","year":"2003","journal-title":"Proc Natl Acad Sci."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100014_bib0535","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood.2020005382","article-title":"Thrombospondin-1 promotes hemostasis through modulation of cAMP signaling in blood platelets","volume":"137","author":"Aburima","year":"2021","journal-title":"Blood."},{"issue":"11","key":"10.1016\/j.aicoj.2025.100014_bib0540","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V108.11.1755.1755","article-title":"Thrombospondin-1 (TSP1) Promotes Thrombin Generation on the Surface of Fibroblasts (HS-68) and Induces Up-Regulation of Connective Tissue Growth Factor (CTGF) Gene and Protein Expression","volume":"108","author":"Manns","year":"2006","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100014_bib0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019654","article-title":"Thrombospondin-1 contributes to mortality in murine sepsis through effects on innate immunity","volume":"6","author":"McMaken","year":"2011","journal-title":"PloS One."},{"key":"10.1016\/j.aicoj.2025.100014_bib0550","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bios.2013.12.012","article-title":"Highly sensitive and quantitative human thrombospondin-1 detection by an M55 aptasensor and clinical validation in patients with atherosclerotic disease","volume":"55","author":"Ji","year":"2014","journal-title":"Biosens Bioelectron."},{"key":"10.1016\/j.aicoj.2025.100014_bib0555","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12967-020-02342-8","article-title":"Kinin B1 receptor: a potential therapeutic target in sepsis-induced vascular hyperpermeability","volume":"18","author":"Ruiz","year":"2020","journal-title":"J Transl Med."},{"issue":"9","key":"10.1016\/j.aicoj.2025.100014_bib0560","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/ph13090215","article-title":"Kinins and Their Receptors in Infectious Diseases","volume":"13","author":"Dagnino","year":"2020","journal-title":"Pharmaceuticals."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0565","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cyto.a.20056","article-title":"RNA and DNA aptamers in cytomics analysis","volume":"59A","author":"Ulrich","year":"2004","journal-title":"Cytometry A."},{"key":"10.1016\/j.aicoj.2025.100014_bib0570","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.talanta.2012.11.016","article-title":"Aptamer-capture based assays for human neutrophil elastase","volume":"106","author":"Cheng","year":"2013","journal-title":"Talanta."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0575","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.thromres.2007.05.013","article-title":"Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation","volume":"121","author":"Song","year":"2008","journal-title":"Thromb Res."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0580","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3343\/alm.2014.34.2.85","article-title":"Changes in Plasma Levels of Natural Anticoagulants in Disseminated Intravascular Coagulation: High Prognostic Value of Antithrombin and Protein C in Patients with Underlying Sepsis or Severe Infection","volume":"34","author":"Choi","year":"2014","journal-title":"Ann Lab Med."},{"issue":"4","key":"10.1016\/j.aicoj.2025.100014_bib0585","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.chembiol.2009.03.007","article-title":"An Exosite-Specific ssDNA Aptamer Inhibits the Anticoagulant Functions of Activated Protein C and Enhances Inhibition by Protein C Inhibitor","volume":"16","author":"M\u00fcller","year":"2009","journal-title":"Chem Biol."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0590","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65262-3","article-title":"Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock","volume":"14","author":"Lehner","year":"2024","journal-title":"Sci Rep."},{"issue":"6","key":"10.1016\/j.aicoj.2025.100014_bib0595","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/jth.12201","article-title":"Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein","volume":"11","author":"Waters","year":"2013","journal-title":"J Thromb Haemost."},{"issue":"20","key":"10.1016\/j.aicoj.2025.100014_bib0600","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1182\/blood-2010-10-311936","article-title":"Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor","volume":"117","author":"Waters","year":"2011","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0605","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.chest.2017.01.010","article-title":"Endothelial Permeability and Hemostasis in Septic Shock: Results From the ProCESS Trial","volume":"152","author":"Hou","year":"2017","journal-title":"Chest."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0610","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/nat.2016.0637","article-title":"A Conjugate of Two tPA-Binding RNA Aptamers Efficiently Inhibits Fibrinolysis","volume":"27","author":"Bjerregaard","year":"2017","journal-title":"Nucleic Acid Ther."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100014_bib0615","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1158\/1541-7786.MCR-12-0349","article-title":"Targeting Tumor Cell Invasion and Dissemination In Vivo by an Aptamer That Inhibits Urokinase-type Plasminogen Activator through a Novel Multifunctional Mechanism","volume":"10","author":"Botkjaer","year":"2012","journal-title":"Mol Cancer Res."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0620","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1186\/cc9412","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 levels predict outcomes of pneumonia-related septic shock patients: a prospective observational study","volume":"15","author":"Yang","year":"2011","journal-title":"Crit Care."},{"issue":"2","key":"10.1016\/j.aicoj.2025.100014_bib0625","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/oli.2008.0177","article-title":"Antimetastatic Potential of PAI-1\u2013Specific RNA Aptamers","volume":"19","author":"Blake","year":"2009","journal-title":"Oligonucleotides."},{"key":"10.1016\/j.aicoj.2025.100014_bib0630","author":"Meyers"},{"key":"10.1016\/j.aicoj.2025.100014_bib0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2025.101350","article-title":"The recent blooming of therapeutic aptamers","volume":"102","author":"Cesarini","year":"2025","journal-title":"Mol Aspects Med."},{"issue":"13","key":"10.1016\/j.aicoj.2025.100014_bib0640","article-title":"VEGF Inhibition Study in Ocular Neovascularization\u20131 (VISION\u20131): Efficacy Results From Phase II\/III MacugenTM (Pegaptanib Sodium) Clinical Trials","volume":"45","author":"Gragoudas","year":"2004","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100014_bib0645","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11123201","article-title":"Nucleic Acid Aptamer-Based Biosensors: A Review","volume":"11","author":"Sequeira-Antunes","year":"2023","journal-title":"Biomedicines."},{"issue":"16","key":"10.1016\/j.aicoj.2025.100014_bib0650","doi-asserted-by":"crossref","first-page":"12779","DOI":"10.1074\/jbc.M111.300772","article-title":"Potent Anticoagulant Aptamer Directed against Factor IXa Blocks Macromolecular Substrate Interaction","volume":"287","author":"Sullenger","year":"2012","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0655","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10517-009-0627-7","article-title":"Inhibition of Thrombin Activity with DNA-Aptamers","volume":"148","author":"Dobrovolsky","year":"2009","journal-title":"Bull Exp Biol Med."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0660","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3103\/S0027131415010095","article-title":"The structure of G-quadruplex thrombine-binding DNA aptamer RA36","volume":"70","author":"Yuminova","year":"2015","journal-title":"Mosc Univ Chem Bull."},{"issue":"5","key":"10.1016\/j.aicoj.2025.100014_bib0665","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1538-7836.2012.04679.x","article-title":"A high affinity, antidote\u2010controllable prothrombin and thrombin\u2010binding RNA aptamer inhibits thrombin generation and thrombin activity","volume":"10","author":"Bompiani","year":"2012","journal-title":"J Thromb Haemost."},{"issue":"1","key":"10.1016\/j.aicoj.2025.100014_bib0670","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1021\/acs.jmedchem.0c01711","article-title":"Improving Thermodynamic Stability and Anticoagulant Activity of a Thrombin Binding Aptamer by Incorporation of 8-trifluoromethyl-2\u2032-deoxyguanosine","volume":"64","author":"Bao","year":"2021","journal-title":"J Med Chem."},{"issue":"19","key":"10.1016\/j.aicoj.2025.100014_bib0675","doi-asserted-by":"crossref","first-page":"10680","DOI":"10.1093\/nar\/gkaa800","article-title":"Evolution of a highly functional circular DNA aptamer in serum","volume":"48","author":"Mao","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.aicoj.2025.100014_bib0680","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1021\/acs.bioconjchem.0c00525","article-title":"Assessment of Aptamer-Targeted Contrast Agents for Monitoring of Blood Clots in Computed Tomography and Fluoroscopy Imaging","volume":"31","author":"Koudrina","year":"2020","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.aicoj.2025.100014_bib0685","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7481","article-title":"Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA\/L-DNA aptamer","volume":"6","author":"Yatime","year":"2015","journal-title":"Nat Commun."},{"key":"10.1016\/j.aicoj.2025.100014_bib686","doi-asserted-by":"crossref","DOI":"10.1007\/s00134-025-08280-7","article-title":"Low plasminogen and impaired fibrinolysis in sepsis-induced DIC: a potential mechanistic link and potential therapeutic perspective","author":"Helms","year":"2026","journal-title":"Intensive Care Medicine"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S211058202502028X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S211058202502028X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:38:28Z","timestamp":1791970708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S211058202502028X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":138,"alternative-id":["S211058202502028X"],"URL":"https:\/\/doi.org\/10.1016\/j.aicoj.2025.100014","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging role of nucleic acid aptamers in sepsis-induced coagulopathy: Future perspectives in diagnostics and therapeutics","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aicoj.2025.100014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise (French Intensive Care Society).","name":"copyright","label":"Copyright"}],"article-number":"100014"}}